Q2 2010 Canadian Healthcare Review...

Financing, A weak financing climate for Canadian public healthcare companies continued in the second quarter. Gross proceeds of completed equity and convertible debt financings amounted to $72.7 million (Appendix 1), bringing the total for the first half of 2010 to $308.7 million. Two issuers accounted for more than half of the activity in the second quarter: Aeterna Zentaris completed two equity financings totaling US$27.1...

Q1 2010 Canadian Healthcare Review...

Financing Public Canadian healthcare companies completed equity and convertible debt financings during this quarter for total gross proceeds of $236.0 million (Appendix 1). The largest financing in the sector was the only financing in the Services group, $86.3 million by Extendicare. The largest financing in the Therapeutics group was $34.5 million from a rights offering by Wex Pharmaceuticals, with 97.6% of the shares being...

CEOs Speak Out About Issues Affecting Their Abilit...

By Gail Garland In the summer of 2009, the CEOs of Ontario’s SME bioscience companies came together at the open invitation of Ontario Bioscience Industry Organization (OBIO) for a meeting hosted in Gowlings Toronto boardroom. On the agenda was a discussion of the future of Ontario’s bioscience industry and its unprecedented lack of access to capital, a worsening situation threatening the sustainability of the...

BURRILL CANADIAN BIOTECH NEWS...

“The Ontario Government is listening to our industry and recognizing the economic potential of a vibrant and growing bioscience industry that can produce many of the medical therapies and technologies we now import and can create jobs”, said Dr. David Young, chair of the board of directors of OBIO, and managing partner, Actium Equity Partners. View PDF: ...

Innovation and Commercialization Seminar Series at...

University of Toronto, Faculty of Medicine is hosting 3 seminars on Innovation and Commercialization: Commercialization:  March 18 (view pdf) Intellectual Property:  April 15 Business Planning:  May...

OBIO Releases Biotechnology Industry Consultation ...

OBIO Biotechnology Industry Consultation Report November 2009 (Download PDF / View Online) Executive Summary The Ontario government has recognized the importance of the emerging knowledge economy to the province’s future prosperity. The biotechnology industry is an important part of a knowledge economy. The confluence of external and internal factors has converged to create an unprecedented crisis in this sector. The...

Review of the Canadian Healthcare Sector in 2009 b...

Public Canadian healthcare companies operate in a complex, challenging and constantly changing global environment. In 2009, some companies celebrated success, most focused on survival and a few did not make it. In this review, we will look at some of the environmental changes and company-specific events of 2009 which characterize this challenging year and will impact the future of this sector.The sector raised a total of...

The Canadian Blueprint: Beyond Moose and Mountains...

Biotechnology is creating products and processes that improve our quality of life. Just as importantly, biotechnology is also creating high-quality jobs for Canadians in every part of the country; rewarding, knowledge economy jobs. No matter where we live, we all have a stake in the bio-based economy. The “Canadian Blueprint” is a strategy that will enable us to take full advantage of all the opportunities biotechnology...

New Fund Expands Options for Cash-strapped Biotech...

Ottawa (Dec. 16, 2009) – The new Tandem fund of $300 million announced last week presents a much-needed financing option for Canada’s biotechnology industry. The Fund received investments from the Business Development Bank of Canada (BDC), and Export Development Canada (EDC), contributing $80 and $75 million respectively to the Fund.”The fact that biotech firms are able to apply for funding from this new source...

Funding Opportunities in 2009-2010 for Bioscience ...

Funding Opportunities in 2009-2010 for Bioscience Companies:  What CEOs Need to Know About Ontario’s ETF and BIP Programs.  This OBIO event was held on Sept. 11, 2009 in Mississauga. The panel presentations are archived within the “Ministry of Research and Innovation” folder at:   http://hosting.epresence.tv/UTM/1/Page/Published/99.aspx Click on the “OBIO – OETF Launch Panel” event.  Password:...